Skip to content

C49.8 ICD-10-CM Code: Malignant neoplasm of overlapping sites of connective and soft tissue

C49.8 maps to CMS-HCC V28 21. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC49.8

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of mesothelial and soft tissue (C45-C49)

C49.8

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Malignant neoplasm of overlapping sites of connective and soft tissue

A malignant tumor of connective and soft tissue that involves multiple overlapping anatomical sites rather than being confined to one location.

Buddy the Bee presenting code insight

Buddy Insight

Malignant neoplasm of overlapping sites of connective and soft tissue indicates a sarcoma that spans multiple anatomical regions and cannot be classified to a single site.

CMS-HCC V28

HCC 21

Coefficient HCC 21: 0.671 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Historical

Not used for CY2026 payment

ACA/HHS

HCC 010

Code-level coefficient reference

ESRD/PACE

HCC 10

Code-level coefficient reference

RXHCC

HCC 22

Code-level coefficient reference

Inclusion Terms

Official
  • Primary malignant neoplasm of two or more contiguous sites of connective and soft tissue

Excludes 2

Official
  • Kaposi's sarcoma of soft tissue (C46.1)Inherited from C49
  • malignant neoplasm of heart (C38.0)Inherited from C49
  • malignant neoplasm of peripheral nerves and autonomic nervous system (C47.-)Inherited from C49
  • malignant neoplasm of peritoneum (C48.2)Inherited from C49
  • malignant neoplasm of retroperitoneum (C48.0)Inherited from C49
  • malignant neoplasm of uterine ligament (C57.3)Inherited from C49
  • mesothelioma (C45.-)Inherited from C49

Includes

Official
  • malignant neoplasm of blood vesselInherited from C49
  • malignant neoplasm of bursaInherited from C49
  • malignant neoplasm of cartilageInherited from C49
  • malignant neoplasm of fasciaInherited from C49
  • malignant neoplasm of fatInherited from C49
  • malignant neoplasm of ligament, except uterineInherited from C49
  • malignant neoplasm of lymphatic vesselInherited from C49
  • malignant neoplasm of muscleInherited from C49
  • malignant neoplasm of synoviaInherited from C49
  • malignant neoplasm of tendon (sheath)Inherited from C49

Excludes 1

Official
  • malignant neoplasm of cartilage (of):Inherited from C49
  • articular (C40-C41)Inherited from C49
  • larynx (C32.3)Inherited from C49
  • nose (C30.0)Inherited from C49
  • malignant neoplasm of connective tissue of breast (C50.-)Inherited from C49

Code First

Official

No Code First sequencing instructions are included in this display for C49.8. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for C49.8. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for C49.8. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance
Pathology confirming malignant soft tissue neoplasm spanning multiple sites
Documentation of all anatomical regions involved
Imaging showing the overlapping nature of the tumor
Explanation of why a single-site code is insufficient

MEAT Support

HCC Buddy guidance
Pathology confirming malignant soft tissue neoplasm spanning multiple sites
Documentation of all anatomical regions involved
Imaging showing the overlapping nature of the tumor
Explanation of why a single-site code is insufficient

Audit Caution

HCC Buddy guidance
Using overlapping code when the tumor can be classified to a single site
Confusing overlapping sites (known multiple sites) with unspecified site (unknown location)
Coding metastatic disease involving multiple sites as overlapping sites of a primary tumor
Not documenting which sites overlap to support the code selection

Common Mistakes

HCC Buddy guidance
C49.0-C49.5 (Site-specific soft tissue codes) — use when tumor is confined to one region
C49.9 (Soft tissue, unspecified) — for unknown site, not known multiple sites
C49.6 (Trunk, unspecified) — for unknown trunk location, different concept
C80.0 (Disseminated malignant neoplasm) — widely metastatic disease is different from overlapping sites

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C49.8 an HCC code?

Yes. C49.8 (Malignant neoplasm of overlapping sites of connective and soft tissue) maps to HCC 21, Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.671. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: C49.8 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
C49.8
Description
Malignant neoplasm of overlapping sites of connective and soft tissue
HCC (V28)
HCC 21 — Lymphoma and Other Cancers
RAF reference coefficient
0.671
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 21, Lymphoma and Other Cancers
0.671
ESRDHCC 10, Lymphoma and Other Cancers
Not separately weighted
RxHCCHCC 22, Prostate, Breast, Bladder, and Other Cancers and Tumors
Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work C49.8 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for C49.8

For C49.8, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C49.8 is the ICD-10-CM diagnosis code for malignant neoplasm of overlapping sites of connective and soft tissue. A malignant tumor of connective and soft tissue that involves multiple overlapping anatomical sites rather than being confined to one location. C49.8 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of mesothelial and soft tissue (c45-c49).

Under the CMS-HCC V28 risk adjustment model, C49.8 maps to Lymphoma and Other Cancers (HCC 21) with a source-labeled community, non-dual, aged reference coefficient of 0.671. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

Document all involved sites when coding overlapping neoplasms. For C49.8, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C49.8 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Document all involved sites when coding overlapping neoplasms
  • This code indicates the tumor crosses anatomical boundaries; ensure documentation supports this finding

Clinical Significance

Malignant neoplasm of overlapping sites of connective and soft tissue indicates a sarcoma that spans multiple anatomical regions and cannot be classified to a single site. This typically represents extensive local disease and may indicate a large tumor crossing anatomical boundaries.

Documentation Requirements

  • Pathology confirming malignant soft tissue neoplasm spanning multiple sites
  • Documentation of all anatomical regions involved
  • Imaging showing the overlapping nature of the tumor
  • Explanation of why a single-site code is insufficient
  • Surgical or treatment plan addressing multi-site involvement

Commonly Confused Codes

  • C49.0-C49.5 (Site-specific soft tissue codes): use when tumor is confined to one region
  • C49.9 (Soft tissue, unspecified): for unknown site, not known multiple sites
  • C49.6 (Trunk, unspecified): for unknown trunk location, different concept
  • C80.0 (Disseminated malignant neoplasm): widely metastatic disease is different from overlapping sites

Child Codes

Code Hierarchy

Also searched as

  • C49 8
  • C498

For C49.8, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

C49.8 maps to CMS-HCC V28 category 21, Lymphoma and Other Cancers. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. The mapping identifies a payment HCC category for C49.8. Review its source-labeled HCC coefficient above, check the RAF Calculator with complete member context for CMS-HCC V28 PY2026, and confirm the documentation the chart needs before the code is submitted. HCC Buddy shows no RAF score unless every required source and calculation check passes.

Work C49.8 in HCC Buddy

Open C49.8 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.